Chen Kaiqi, Guan Jingyan, Liu Kaiyang, You Xin, Xu Mimi, Lu Feng, He Yunfan
Department of Plastic and Cosmetic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, P. R. China.
Tissue Eng Part A. 2025 Apr;31(7-8):334-350. doi: 10.1089/ten.TEA.2023.0354. Epub 2024 Jun 27.
Xenotransplantation of acellular adipose matrix (AAM) has come to prominence as an intriguing option for soft tissue reconstruction. However, the presence of immunogenic antigens within AAM can trigger unfavorable immune reactions, leading to inadequate regeneration outcomes. Therefore, the development of advanced technology capable of modulating immune responses is crucial for the therapeutic implementation of AAM xenografts. In this work, an innovative technique is created to bypass the immune system by covering the surface of both AAM and Arg-Gly-Asp (RGD) peptide-modified AAM xenografts with autologous red blood cell (RBC) membrane. The RBC membrane coating remained persistent and exhibited no significant decline even after 21 days. Moreover, it effectively reduced the expression of antigen major histocompatibility complex class 1 (MHC1) on the AAM surface. Following xenogeneic transplantation, the RBC-coated xenografts demonstrated increased expression of the adipogenic factor , , , and and higher numbers of adipocytes. In addition, they exhibited decreased expression of immunological factors, including , , and , and fewer inflammatory cells. These findings indicate that RBC membrane coating successfully suppressed immune responses and promoted increased adipogenesis in AAM xenografts. Therefore, AAM camouflage coating with RBC has a lot of potential as a biomaterial for soft tissue reconstruction in clinical settings.
脱细胞脂肪基质(AAM)的异种移植作为软组织重建的一种有趣选择已崭露头角。然而,AAM中免疫原性抗原的存在可引发不良免疫反应,导致再生效果不佳。因此,开发能够调节免疫反应的先进技术对于AAM异种移植物的治疗应用至关重要。在这项工作中,创建了一种创新技术,通过用自体红细胞(RBC)膜覆盖AAM和精氨酸-甘氨酸-天冬氨酸(RGD)肽修饰的AAM异种移植物的表面来绕过免疫系统。红细胞膜涂层持续存在,即使在21天后也没有明显下降。此外,它有效降低了AAM表面抗原主要组织相容性复合体I类(MHC1)的表达。异种移植后,红细胞包被的异种移植物显示出脂肪生成因子、、、和的表达增加,脂肪细胞数量增多。此外,它们表现出免疫因子、和的表达降低,炎症细胞减少。这些发现表明,红细胞膜涂层成功抑制了免疫反应,并促进了AAM异种移植物中脂肪生成的增加。因此,用红细胞进行AAM伪装涂层作为临床软组织重建的生物材料具有很大潜力。